Phenobarbital: Clinical Trials

5 trials of Phenobarbital, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 1, Terminated 1, Unknown 1
Phase 12Completed 1, Terminated 1

Follow Phenobarbital: new trials by email Literature Review of Phenobarbital trials Research Report on Phenobarbital

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Levetiracetam Injection, Phenobarbital Sodium Injection - Neonatal Seizure, Neonatal Encephalopathy
Phase 2RecruitingUniversity of California, San Diego1332023-03-242026-10-15
Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
Phenobarbital, Clonidine - Neonatal Abstinence Syndrome
Phase 2CompletedUniversity of Tennessee Medical Center252018-10-012021-11-10
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus
Phenobarbital, Valproate - Generalized Convulsive Status Epilepticus
Phase 2UnknownXuanwu Hospital, Beijing1202017-02-162019-07-09
Levetiracetam Treatment of Neonatal Seizures
Oral levetiracetam, Intravenous phenobarbital - Neonatal Seizures
Phase 1 / Phase 2TerminatedChildren's Hospital of Fudan University602015-09-012023-12-29
Efficacy of Intravenous Levetiracetam in Neonatal Seizures
Intravenous levetiracetam, Intravenous phenobarbital - Neonatal Seizures
Phase 1 / Phase 2CompletedRichard H. Haas2802013-03-012019-08-21

Conditions studied

Seizures (2)  ·  Hypoxia-Ischemia, Brain (1)  ·  Neonatal Abstinence Syndrome (1)  ·  Status Epilepticus (1)

Sponsors

Children's Hospital of Fudan University (1)  ·  Richard H. Haas (1)  ·  University of California, San Diego (1)  ·  University of Tennessee Medical Center (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

United States (3)  ·  China (2)  ·  New Zealand (1)

Top investigators

Carrie Brusseau, PharmD (1)  ·  Cynthia M Sharpe, M.D. (1)  ·  Jeff J Gold, M.D. PhD (1)  ·  Richard H Haas, MBBChir (1)  ·  Richard H Haas, MD (1)  ·  Sonya G Wang, M.D. (1)  ·  Wenhao Zhou, Doctor (1)

Results publications

PMID 30289769, PMID 38902005